Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A new Revision: v3.3.4 is added and the previous Revision: v3.3.3 is removed.
    Difference
    0.1%
    Check dated 2026-01-15T04:48:55.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new Locations section appears with Texas as a site, replacing the earlier Texas Locations entry; the HHS Vulnerability Disclosure link is removed.
    Difference
    0.2%
    Check dated 2025-12-24T14:46:21.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Publications section wording updated to replace 'the study results' with 'the results of the study' and to add a version tag (Revision: v3.3.2) while removing the older tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:51:44.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The government funding and operating status notice has been removed from the page, while core study details, eligibility criteria, and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:30:01.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    No significant changes detected in the page contents or structure between screenshots; the primary study details remain the same.
    Difference
    0.4%
    Check dated 2025-10-27T21:11:16.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T08:57:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.